MAB1722

antibody from Abnova Corporation

Targeting: BSG CD147, EMMPRIN, EMPRIN, OK

No application information provided.

Antibody Data

Product number

MAB1722

Provider

Abnova Corporation

Proper citation

Abnova Corporation Cat#MAB1722, RRID:AB_1672383

Product name

BSG monoclonal antibody, clone 2G2

Antibody type

Monoclonal

Description

Mouse monoclonal antibody raised against native BSG.

Isotype

IgG

Antibody clone number

2G2

Storage

Store at -20°C.Aliquot to avoid repeated freezing and thawing.

References

Submitted references

Roles of CD147 on T lymphocytes activation and MMP-9 secretion in systemic lupus erythematosus.

Pistol G, Matache C, Calugaru A, Stavaru C, Tanaseanu S, Ionescu R, Dumitrache S, Stefanescu M
Journal of cellular and molecular medicine 2007 Mar-Apr;11(2):339-48

---

Tumor vesicle-associated CD147 modulates the angiogenic capability of endothelial cells.

Millimaggi D, Mari M, D'Ascenzo S, Carosa E, Jannini EA, Zucker S, Carta G, Pavan A, Dolo V
Neoplasia (New York, N.Y.) 2007 Apr;9(4):349-57

---

Regulation of vascular endothelial growth factor expression by EMMPRIN via the PI3K-Akt signaling pathway.

Tang Y, Nakada MT, Rafferty P, Laraio J, McCabe FL, Millar H, Cunningham M, Snyder LA, Bugelski P, Yan L
Molecular cancer research : MCR 2006 Jun;4(6):371-7

---

Membrane type 1 matrix metalloproteinase (MT1-MMP/MMP-14) cleaves and releases a 22-kDa extracellular matrix metalloproteinase inducer (EMMPRIN) fragment from tumor cells.

Egawa N, Koshikawa N, Tomari T, Nabeshima K, Isobe T, Seiki M
The Journal of biological chemistry 2006 Dec 8;281(49):37576-85

---

A small interfering CD147-targeting RNA inhibited the proliferation, invasiveness, and metastatic activity of malignant melanoma.

Chen X, Lin J, Kanekura T, Su J, Lin W, Xie H, Wu Y, Li J, Chen M, Chang J
Cancer research 2006 Dec 1;66(23):11323-30